Cronos Group Inc.
CRONNASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 23, 2026 close
- Market cap
- $1.26B
- P/E (TTM)
- 18.02
- Forward P/E
- 9.41
- Dividend yield
- -
- 52-week range
- $2.28$3.61
- Volume (live)
- -
- Avg. volume (3M)
- 873.10K
Cronos Group (CRON) Stock Price & Financial Analysis
Cronos Group Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.30 - $3.43 |
|---|---|
| 52-Week High | $3.61 |
| 52-Week Low | $2.28 |
| Open | $3.43 |
| Volume (last close) | 816.69K |
| Average Volume (3M) | 873.10K |
| Revenue (TTM) | 179.03M |
|---|---|
| Net Income (TTM) | 69.73M |
| Free Cash Flow (TTM) | 49.70M |
| EPS (TTM) | $0.18 |
| Profit Margin | 38.95% |
| Operating Margin | -2.82% |
| Return on Equity (ROE) | 6.24% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 1.26B |
|---|---|
| Shares Outstanding | 375.06M |
| P/E Ratio (TTM) | 18.02 |
| Forward P/E | 9.41 |
| Price to Sales (P/S) | 7.02 |
| Price to Book (P/B) | 1.12 |
| EV/EBITDA | 36.39 |
| 50-Day MA | $3.27 |
|---|---|
| 200-Day MA | $2.83 |
| 1-Year Change | +38.91% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Cronos Group at a Glance
As of the Oct 23, 2026 close, Cronos Group (CRON) has a market capitalization of $1.26B. The stock trades at 18.0× trailing earnings, 9.4× forward earnings and 7.0× sales. Over the trailing twelve months it earned $69.73M on revenue of $179.03M (a 39.0% profit margin) and generated $49.70M of free cash flow. Revenue grew 37.4% year over year.
As of its latest reported balance sheet, it holds $467.02M in cash and securities against $1.29M of debt, a net cash position of $465.72M.
Cronos Group does not currently pay a dividend.
The share price is up 38.9% over the past year. At $3.35 (the Oct 23, 2026 close) it sits within its 52-week range of $2.28 to $3.61, above its 200-day moving average of $2.83.
Based on 2 professional analyst ratings from the past 90 days, the consensus is Buy.
Frequently Asked Questions About Cronos Group
What is the current stock price for CRON?
As of the Oct 23, 2026 close, CRON stock trades at $3.35. The 52-week range is $2.28–$3.61, with a day range of $3.30–$3.43.
What is the P/E ratio for CRON?
As of the Oct 23, 2026 close, Cronos Group's trailing twelve-month (TTM) P/E ratio is 18.0, meaning investors pay $18.0 for every $1 of annual earnings. The forward P/E is 9.4, reflecting analyst expectations for future earnings. Cronos Group operates in the Healthcare sector.
Does CRON pay dividends?
Cronos Group does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for CRON?
Based on ratings from 2 professional analysts over the last 90 days, the consensus for CRON is Buy.
What is the market cap of CRON?
As of the Oct 23, 2026 close, Cronos Group's market capitalization is $1.26B, classifying it as a small-cap company. Cronos Group operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.